Evidence map›Paper›PMID 30612280›Full record

ArticleMolecular biology reports2019

Investigation of possible effects of microRNAs involved in regulation of lipid metabolism in the pathogenesis of atherosclerosis.

Aysegul Gorur, Ahmet Celik, Didem Derici Yildirim, Ahmet Gundes, Lulufer Tamer

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Genomic Variants and Multilevel Regulation ofJournal of cardiovascular development and disease · 2021
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aysegul GorurFaculty of Medicine, Department of Medical Biochemistry, Mersin University, Yenisehir, 33343, Mersin, Turkey. aysegulgorur82@gmail.com.ORCID http://orcid.org/0000-0002-8463-8663
Ahmet CelikFaculty of Medicine, Department of Internal Medicine, Cardiology, Mersin University, Yenisehir, 33343, Mersin, Turkey.ORCID http://orcid.org/0000-0002-9417-7610
Didem Derici YildirimFaculty of Medicine, Department of Biostatistics and Medical Informatics, Mersin University, Yenisehir, 33343, Mersin, Turkey.ORCID http://orcid.org/0000-0001-7709-6133
Ahmet GundesFaculty of Medicine, Department of Internal Medicine, Cardiology, Mersin University, Yenisehir, 33343, Mersin, Turkey.ORCID http://orcid.org/0000-0002-6901-3403
Lulufer TamerFaculty of Medicine, Department of Medical Biochemistry, Mersin University, Yenisehir, 33343, Mersin, Turkey.ORCID http://orcid.org/0000-0002-0997-0260

Funding

Mersin Üniversitesi 2015-TP3-1185
6 · The paper itself

Abstract

Due to being stable in the circulatory system plasma miRNAs have been detected in various diseases including coronary artery disease (CAD) which is the major cause of mortality and morbidity worldwide. Atherosclerosis is the major cause of CAD. The first and most important event in the progression of atherosclerosis is endothelial dysfunction and accumulation of the lipids in the arterial wall. Recent studies have shown that different expression levels of lipid metabolism-related miRNAs associated with the pathogenesis of atherosclerosis. Therefore, in this current study, we aimed to investigate the possible effects of lipid metabolism-related miRNAs in plasma of patients with CAD. miRNA analysis was performed by high throughput quantitative PCR method using RNA samples isolated from 46 patients with CAD and 43 non-CAD or control. Data were analyzed using SPSS software version 17 and GeneGlobe Data Analysis Center by Qiagen. Among 40 miRNAs, 4 miRNAs were markedly up-regulated while 4 miRNAs were down-regulated in patients with CAD compared to the control group. The results have shown that, hsa-mir-144-3p, hsa-miR-222-5p and hsa-miR-133a-5p were statistically different in the patient with CAD compared to the control (p = 0.040, 0.030 and 0.005 respectively). Increased expression of hsa-mir-144-3p, hsa-miR-222-5p and hsa-miR-133a-5p would have associated with presence of the CAD. Furthermore, we suggested that these miRNAs might have been useful markers for early detection of the CAD.

Indexed as

AtherosclerosisBody Mass IndexCase-Control StudiesCoronary StenosisC-Reactive ProteinDown-RegulationFemaleGene Expression ProfilingHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLipid MetabolismMaleMicroRNAsMiddle AgedRisk FactorsUp-RegulationC-Reactive ProteinHydroxymethylglutaryl-CoA Reductase InhibitorsMicroRNAsAtherosclerosisCoronary artery diseaseEarly detectionLipid metabolismMarkerMiRNA

Identifiers

PMID30612280

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.